Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4

Journal of Medicinal Chemistry
2018.0

Abstract

Designing multitarget drugs have raised considerable interest due to their advantages in the treatment of complex diseases such as cancer. Their design constitutes a challenge in antitumor drug discovery. The present study reports a dual inhibition of tubulin polymerization and HDAC activity. On the basis of 1,1-diarylethylenes ( isoCA-4) and belinostat, a series of hybrid molecules was successfully designed and synthesized. In particular compounds, 5f and 5h were proven to be potent inhibitors of both tubulin polymerization and HDAC8 leading to excellent antiproliferative activity.

Knowledge Graph

Similar Paper

Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4
Journal of Medicinal Chemistry 2018.0
Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation
European Journal of Medicinal Chemistry 2018.0
Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors
Bioorganic & Medicinal Chemistry Letters 2019.0
The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
Bioorganic & Medicinal Chemistry 2013.0
Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents
Bioorganic & Medicinal Chemistry 2017.0
Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors
ACS Medicinal Chemistry Letters 2015.0
Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
European Journal of Medicinal Chemistry 2015.0
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
European Journal of Medicinal Chemistry 2022.0
Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity
Bioorganic & Medicinal Chemistry Letters 2013.0
Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
Journal of Medicinal Chemistry 2021.0